Eben Tessari

What is GSK Thinking With Its Latest NDA?

Right... but I don't, nor does anyone outside the committee have access to the application. GKS and Ligand's stock dropped quite a bit on wednesday after the news. I wasn't the only one making assumptions.

I was proffering opinion on comments by member of said committee and was asking anyone who has more regulatory experience than I, to comment and enlighten me.

Waiting until the meeting has concluded and using their positive opinion still doesn't answer the question I asked. Do you have any insight to add or do you just chide those with an opinion?